InvestorsHub Logo
Followers 8
Posts 481
Boards Moderated 0
Alias Born 02/03/2021

Re: None

Monday, 06/21/2021 10:09:41 AM

Monday, June 21, 2021 10:09:41 AM

Post# of 232969
Question sent:

Hi,

Please explain clearly in the cc how you evaluated these clinical improvements for LH trial. For instance, did you ask the patients to score (like between 1 and 10) their experience for each of the symptoms? If so, give us some quantitative information on the actual scores (of LL and placebo) beyond just a general statement that we had clinical improvement over placebo based on what patients said. An average score of 7 vs 3 for a symptom will be more telling/promising than 7 vs 6.

Thanks,



The PR says they interpreted the symptom scores as mild, severe etc. But this could still be ambiguous since one can call a score between 7 to 10 as severe and 3 to 6 moderate. Having actual numbers will be more insightful.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News